Last update 25 Nov 2024

AVID-100

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
AVID 100
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), Tubulin inhibitors
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC35H48ClN3O10S
InChIKeyANZJBCHSOXCCRQ-FKUXLPTCSA-N
CAS Registry139504-50-0

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Squamous Cell CarcinomaPhase 2
US
-06 Sep 2019
Breast CancerPhase 2
US
-12 Apr 2019
Non-Small Cell Lung CancerPhase 2
US
01 Feb 2017
Squamous Cell Carcinoma of Head and NeckPhase 2
US
01 Feb 2017
Triple Negative Breast CancerPhase 2
US
01 Feb 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
Carcinoma
EGFR Overexpression | ER Negative | PR Negative ...
-
rrajurbbpq(tkzcpbcwrh) = G3 asymptomatic lipase elevation, G4 reversible thrombocytopenia vgexzydftc (reibljdjog )
Positive
01 Jul 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free